Rankings
▼
Calendar
ACAD Q1 2016 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4,000
Gross Profit
-$23M
-569275.0% margin
Operating Income
-$50M
-1256550.0% margin
Net Income
-$50M
-1244050.0% margin
EPS (Diluted)
$-0.45
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$41M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$467M
Total Liabilities
$21M
Stockholders' Equity
$445M
Cash & Equivalents
$175M
← FY 2016
All Quarters
Q2 2016 →
